Showing results (591-600 of 3,703) with videos related to

Sort By:
Pageof 371
Pharmacology & Therapeutics|January 4, 2014
Epigenetic drugs as immunomodulators for combination therapies in solid tumorsLuca Sigalotti, Elisabetta Fratta, Sandra Coral, et al.
Pharmacology & Therapeutics|June 17, 2014
New pharmacological approaches for cystic fibrosis: promises, progress, pitfallsScott C Bell, Kris De Boeck, Margarida D Amaral
Pharmacology & Therapeutics|April 5, 2021
The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studiesYa-Qun Zhou, Wei Mei, Xue-Bi Tian, et al.
Pharmacology & Therapeutics|August 25, 2020
The opioid-P2Y12 inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarctionHimawan Fernando, James A Shaw, Paul S Myles, et al.
Pharmacology & Therapeutics|July 13, 2020
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbiditiesJames Jiqi Wang, Matthew L Edin, Darryl C Zeldin, et al.
Pharmacology & Therapeutics|August 8, 2020
TSLP as druggable target - a silver-lining for atopic diseases?Partho Protim Adhikary, Zheng Tan, Brent D G Page, et al.
Pharmacology & Therapeutics|August 8, 2020
Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug eliminationJinghui Zhang, Haoxun Wang, Yunzhou Fan, et al.
Pharmacology & Therapeutics|April 3, 2021
Strategies targeting FLT3 beyond the kinase inhibitorsMohammed F Almatani, Atham Ali, Sandra Onyemaechi, et al.
Pharmacology & Therapeutics|August 19, 2020
NRF2 in human neoplasm: Cancer biology and potential therapeutic targetYang Liu, Fengchao Lang, Chunzhang Yang
Pharmacology & Therapeutics|August 11, 2020
The birth of artemisininNan Ma, Ziyue Zhang, Fulong Liao, et al.
Pageof 371